Immutrix Therapeutics, Inc.
Amendment
CIK: 0001656200·Biotechnology·DELAWARE·Filed: Oct 12, 2018
Total Offering
$16,000,000
Amount Sold
$5,277,500
Investors
26
First Sale
Nov 13, 2017
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Carol A. Rae | Related Person |
| Leroy Ketel | Related Person |
| Brent Phillips | Related Person |
Company
SEC Filing
0001656200-18-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free